Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis
Harvard Business
JUNE 13, 2016
Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.
Let's personalize your content